II. Major tranquilizers.
Kehoe MJ.
South Med J. 1971 Apr;64(4):403-10. doi: 10.1097/00007611-197104000-00005.
Tardive Tourette syndrome.
DeVeaugh-Geiss J.
Neurology. 1980 May;30(5):562-3. doi: 10.1212/wnl.30.5.562.
Methadone withdrawal psychosis.
Levinson I, Galynker II, Rosenthal RN.
J Clin Psychiatry. 1995 Feb;56(2):73-6.
Lysosomal membrane permeabilization mediated apoptosis involve in perphenazine-induced hepatotoxicity in vitro and in vivo.
Tao L, Qing Y, Cui Y, Shi D, Liu W, Chen L, Cao Y, Dai Z, Ge X, Zhang L.
Toxicol Lett. 2022 Aug 15;367:76-87. doi: 10.1016/j.toxlet.2022.07.814. Epub 2022 Jul 29.
Suicide with amitriptyline-perphenazine-combination.
Winek CL, Fochtman FW, Collom WD.
Pa Med. 1968 Sep;71(9):71.
[Poisoning due to tricyclic antidepressants in children and adolescents].
Rollin P, Antaki AJ.
Can Med Assoc J. 1979 Apr 21;120(8):951-6.
Clinical trials design lessons from the CATIE study.
Kraemer HC, Glick ID, Klein DF.
Am J Psychiatry. 2009 Nov;166(11):1222-8. doi: 10.1176/appi.ajp.2009.08121809. Epub 2009 Oct 1.
Neuroleptic malignant syndrome during perphenazine treatment.
Nielsen D, Aunsholt NA, Andersen PT.
Pharmacol Toxicol. 1987 Mar;60(3):221-2. doi: 10.1111/j.1600-0773.1987.tb01738.x.
Tardive akathisia.
Rapoport A, Skomorovsky M.
Mov Disord. 1990;5(2):181-2.
The relationship between blood perphenazine levels, early resolution of psychotic symptoms, and side effects.
Mazure CM, Nelson JC, Jatlow PI, Kincare P, Bowers MB Jr.
J Clin Psychiatry. 1990 Aug;51(8):330-4.
